Using the daily rate of rise in hemoglobin S to manage RBC depletion/exchange treatment in sickle cell disease.

The RoR in HbS is a relatively consistent parameter for individual patients that is unaffected by medication use or procedural Hct targets and may be useful in determining intervals between procedures.